RxDoctor Payments Data

Saurabh Gupta, MD

Interventional Cardiology · Bend, ORNPI 1902873177

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $394,119 of the $549,544 with a category attached, or 71.7%. Medtronic accounts for 88.2% of it on its own, with 10 other manufacturers making up the rest. Among interventional cardiology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$549,544in general payments, 2019–2025

Across 623 payments — averaging $882.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$485K
  • Edwards Lifesciences$58K
  • Abbott$3K
  • Boston Scientific$3K
  • Abiomed$435
  • Cook Medical LLC$228
  • plus $208 from 5 others
$250in research payments, 2019–2025

Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$250

What the payments were for

  • Consulting fees$46,4888%
  • Speaking & faculty fees$394,11972%
  • Travel & lodging$90,50616%
  • Food & beverage$18,4323%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$549,544 in reported general payments places this provider in the 95th percentile of 68 interventional cardiology providers in Oregon.

See all interventional cardiology providers in Oregon

Medicare billing

Part B allowed, 2024
$175,550
Medicare patients
274
Services billed
862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate15$131

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Bend

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →